Paediatric anaesthesia & critical care

Population pharmacokinetics of cefazolin administered as prophylaxis in paediatric patients undergoing cardiac surgery

Anaesth Crit Care Pain MedPublished Prospective observational population pharmacokinetic study

Authors' conclusion

Postoperative cefazolin concentrations in paediatric patients undergoing cardiopulmonary bypass are often inadequate to maintain optimal antimicrobial prophylaxis.

Study context

Population
Paediatric patients undergoing cardiac surgery with CPB receiving cefazolin prophylaxisincluded in PK model
Participants
68 patients
Outcome
Unbound cefazolin concentrations above the MIC for 100% of the dosing interval (fT>MIC), intraoperative and postoperative
Methodological detailssingle-centre, population pharmacokinetic modelling, dosing simulations
  • Single-centre
  • Population pharmacokinetic modelling
  • Dosing simulations

Main finding

As reported in the abstract

Target attainment with conventional dosing (preop 50 mg/kg, intraop 25 mg/kg 3-hourly, postop 25 mg/kg 8-hourly) · postoperative

Subtherapeutic concentrations postoperatively in up to this proportion of patients

16.8%

Observational data: associations, not effects.

Original publication

Population pharmacokinetics of cefazolin administered as prophylaxis in paediatric patients undergoing cardiac surgery. Anaesth Crit Care Pain Med. Published 29 October 2025. doi:10.1016/j.accpm.2025.101653

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.